• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcarePharmaceuticalsBeta Drugs
    Picture of Beta Drugs logo

    BETA — Beta Drugs Share News

    IN₹1,894.600.000.00%
    in flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapHigh Flyer
    • Market Cap
      IN₹21.00bn
    • Enterprise Value
      IN₹21.24bn
    • Revenue
      IN₹3.85bn
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • BETA Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    BETA Dividends
    • Brief: Beta Drugs Receives Oncology Portfolio Approvals In Azerbaijan

      22/09/2026 04:32
    • India's Beta Drugs jumps after regulatory milestones in Azerbaijan, Philippines

      22/04/2026 06:37
    • Brief: Beta Drugs Achieves Regulatory Milestones In Azerbaijan And Philippines

      22/04/2026 04:48
    • Brief: Beta Drugs To Buy 66.09% Of Nivian Life Sciences For 694 MLN Rupees

      09/01/2026 12:34
    • Brief: Beta Drugs Receives Dcgi Approval For Methotrexate Oral Solution

      16/10/2025 08:02
    • Brief: Beta Drugs To Consider Raising Of Funds

      16/10/2024 12:19
    • Brief: Beta Drugs To Write Off Investment Made Amounting $88,000 In Beta Ubk. International

      07/11/2023 12:45
    • Brief: Beta Drugs's Baddi Oncology Manufacturing Plant Receives ANVISA Approval

      20/04/2023 04:35
    • Brief: Beta Drugs Receives Drug Controller General Of India Nod To Launch Enzalutamide 160Mg

      24/03/2023 07:48

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.